Immuneering Corp — Director's Dealing 2021

Jul 30, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Immuneering Corp (IMRX)
CIK: 0001790340
Period of Report: 2021-07-29

Reporting Person: KEATING LAURIE (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$4.12	2031-03-17	Class A Common Stock (60074)		Direct

Footnotes

F1: The option vests and becomes exercisable as to 25% of the underlying shares on March 18, 2022 and then in equal monthly installments over the subsequent three years, subject to Ms. Keating's continued service on the Issuer's board of directors through each applicable vesting date.